Why This Biotech Dealmaker — Tied To Merck, Travere — Charged Higher
Reported by Yahoo Finance · investors.com · August 6, 2026
Ligand stock landed in a profit-taking zone Thursday on a strong second-quarter report and an earnings guidance hike.
What the tape says
What to watch: AI infrastructure spend continues to concentrate in compute, memory, and power equipment.
Market reaction today: $MRK -1.24%
Tone and severity are deterministic keyword classification — not a prediction, a member vote, or a recommendation. Figures are extracted from the headline as published. Wook does not republish Yahoo Finance's reporting.
Your read
Discussion
No one has weighed in yet. Start the discussion on this story.
Headline and link are attributed to Yahoo Finance. Wook of Wall Street is an independent research tool and is not affiliated with Yahoo Finance. Nothing here is financial advice or a recommendation — research and educational content only.